Cover Image
Market Research Report
Product code 
1043893

Intelligent Asthma Monitoring Devices Market by Product (Wearable Asthma Monitoring Devices and Smart Inhalers) and End User (Hospitals, Clinics, and Home Use): Global Opportunity Analysis and Industry Forecast, 2021-2030

Published: | Allied Market Research | 183 Pages | Delivery time: 2-3 business days

Price

Back to Top
Intelligent Asthma Monitoring Devices Market by Product (Wearable Asthma Monitoring Devices and Smart Inhalers) and End User (Hospitals, Clinics, and Home Use): Global Opportunity Analysis and Industry Forecast, 2021-2030
Published: October 31, 2021
Allied Market Research
Content info: 183 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The global intelligent asthma monitoring devices market was valued at $180.5 million in 2020, and is projected to reach $1,696.7 million by 2030.

Asthma is a condition in which airways narrow and swell and may produce extra mucus, thus making breathing difficult and triggering cough. This further results in a whistling sound (wheezing) while breathing out and shortness of breath. It requires ongoing management using medication, and a person will often administer these medications using a range of devices, including inhalers and nebulizers. People will often use devices to effectively deliver asthma medication to the airways. Inhalers and nebulizers are the most common devices for administering asthma drugs.

Intelligent asthma monitoring devices are to monitor asthma and prevent asthma attacks & related complications. The growth of the global intelligent asthma monitoring devices market is driven by global increase in air pollution. In addition, increase in population susceptible to indoor air pollutants and alarming rise in prevalence of COPD & asthma globally notably contribute toward the market growth. Moreover, increase in adherence to smart inhalers and transformation from physician-centered to the patient-centered model, rise in collaboration between pharmaceutical companies and smart inhaler manufacturers, and surge in incidence of asthma cases fuel the growth of the market. However, misusing data and data privacy and resistance toward adoption of smart inhalers are expected to restrain the market growth. Conversely, increased focus toward advanced treatment protocols, significant unmet needs in respiratory care, and increase in healthcare expenditure in developing countries are expected to provide lucrative opportunities to the market players.

The key factors that drive the market growth include increase in indoor air pollutants, rise in prevalence of chronic obstructive pulmonary disease (COPD) & asthma, and surge in adoption of smart inhalers drive the growth of the global intelligent asthma monitoring devices market.

The global intelligent asthma monitoring devices market is segmented into product, end user, and region. Depending on product, the market is bifurcated into wearable asthma monitoring devices and smart inhalers. The smart inhalers segment is further segregated into inhalers and nebulizers. The inhaler segment is subsegmented into dry powdered inhalers and metered dose inhalers. On the basis of end user, the market is categorized into hospital, clinics, and home use.

Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players operating in the global intelligent asthma monitoring devices market are Adherium, Astrazeneca, Cohero Health Inc, Glaxosmithkline PLC, Health Care Originals, Koninklijke Philips N.V., Propeller Health, Teva Pharmaceuticals Industries Ltd., Vectura group Plc., and Volansys Technologies.

Key benefits for stakeholders

The study provides an in-depth analysis of the global intelligent asthma monitoring devices market, with current trends and future estimations to elucidate the imminent investment pockets.

Comprehensive analysis of factors that drive and restrict the market growth is provided. The market forecast is studied from 2021 to 2030.

Quantitative analysis of the industry from 2020 to 2030 is presented to enable stakeholders to capitalize on prevailing market opportunities.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

Key market segments

By Product

  • Wearable asthma Monitoring Devices
  • Smart Inhalers
  • Inhalers
  • Dry Powdered Inhalers (DPI's)
  • Metered Dose Inhalers (MDI's)
  • Nebulizers

By End User

  • Hospitals
  • Clinics
  • Home Use

BY REGION

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Adherium
  • Astrazeneca PLC
  • Cohero Health Inc
  • Glaxosmithkline PLC
  • Health Care Originals
  • Koninklijke Philips N.V
  • Propeller Health
  • Teva Pharmaceuticals Industries Ltd
  • Vectura group Plc
  • Volansys Technologies.
Product Code: A04762

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key Market Segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top player positioning
  • 3.3.Market dynamics
    • 3.3.1.Drivers
      • 3.3.1.1.Global increase in air pollution
      • 3.3.1.2.Increase in population susceptible to indoor air pollutants
      • 3.3.1.3.Increase in prevalence of COPD and asthma globally
      • 3.3.1.4.Expected increase in adherence to smart inhalers
      • 3.3.1.5.Increase in collaboration between pharmaceutical companies and smart inhaler manufacturers
      • 3.3.1.6.Rise in incidences of asthma cases
    • 3.3.2.Restraints
      • 3.3.2.1.Misusing data and data privacy
      • 3.3.2.2.Resistance toward adoption of smart inhalers
    • 3.3.3.Opportunities
      • 3.3.3.1.Increased focus toward advanced treatment protocols
      • 3.3.3.2.Significant unmet need in respiratory care
      • 3.3.3.3.Opportunities in emerging economies
    • 3.3.4.Impact analysis

CHAPTER 4:INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Wearable asthma monitoring devices
    • 4.2.1.Key trends and opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
  • 4.3.Smart inhalers
    • 4.3.1.Key trends and opportunities
    • 4.3.2.Market size and forecast, by type
      • 4.3.2.1.Inhalers
      • 4.3.2.1.1.Market size and forecast
      • 4.3.2.1.2.Key trends and opportunities
      • 4.3.2.1.2.1.Dry powdered inhalers (DPIs)
      • 4.3.2.1.2.2.Metered dose inhalers (MDIs)
      • 4.3.2.2.Nebulizers
    • 4.3.3.Market size and forecast, by region
    • 4.3.4.Market analysis, by country

CHAPTER 5:INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Hospitals
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Homecare
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Clinics
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country

CHAPTER 6:INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key trends and opportunities
    • 6.2.2.North America market size & forecast, by country
      • 6.2.2.1.U.S. market size & forecast, by product
      • 6.2.2.2.U.S. market size & forecast, by end user
      • 6.2.2.3.Canada market size & forecast, by product
      • 6.2.2.4.Canada market size & forecast, by end user
      • 6.2.2.5.Mexico market size & forecast, by product
      • 6.2.2.6.Mexico market size & forecast, by end user
    • 6.2.3.North America market size & forecast, by product
    • 6.2.4.North America market size & forecast, by end user
  • 6.3.Europe
    • 6.3.1.Key trends and opportunities
    • 6.3.2.Europe market size & forecast, by country
      • 6.3.2.1.Germany market size & forecast, by product
      • 6.3.2.2.Germany market size & forecast, by end user
      • 6.3.2.3.France market size & forecast, by product
      • 6.3.2.4.France market size & forecast, by end user
      • 6.3.2.5.UK market size & forecast, by product
      • 6.3.2.6.UK market size & forecast, by end user
      • 6.3.2.7.Italy market size & forecast, by product
      • 6.3.2.8.Italy market size & forecast, by end user
      • 6.3.2.9.Rest of Europe market size & forecast, by product
      • 6.3.2.10.Rest of Europe market size & forecast, by end user
    • 6.3.3.Europe market size & forecast, by product
    • 6.3.4.Europe market size & forecast, by end user
  • 6.4.Asia-Pacific
    • 6.4.1.Key trends and opportunities
    • 6.4.2.Asia-Pacific market size & forecast, by country
      • 6.4.2.1.Japan market size & forecast, by product
      • 6.4.2.2.Japan market size & forecast, by end user
      • 6.4.2.3.China market size & forecast, by product
      • 6.4.2.4.China market size & forecast, by end user
      • 6.4.2.5.India market size & forecast, by product
      • 6.4.2.6.India market size & forecast, by end user
      • 6.4.2.7.Australia market size & forecast, by product
      • 6.4.2.8.Australia market size & forecast, by end user
      • 6.4.2.9.Rest of Asia-Pacific market size & forecast, by product
      • 6.4.2.10.Rest of Asia-Pacific market size & forecast, by end user
    • 6.4.3.Asia-Pacific market size & forecast, by product
    • 6.4.4.Asia-Pacific market size & forecast, by end user
  • 6.5.LAMEA
    • 6.5.1.Key trends and opportunities
    • 6.5.2.LAMEA market size & forecast, by country
      • 6.5.2.1.Brazil market size & forecast, by product
      • 6.5.2.2.Brazil market size & forecast, by end user
      • 6.5.2.3.South Africa market size & forecast, by product
      • 6.5.2.4.South Africa market size & forecast, by end user
      • 6.5.2.5.Saudi Arabia market size & forecast, by product
      • 6.5.2.6.Saudi Arabia market size & forecast, by end user
      • 6.5.2.7.Rest of LAMEA market size & forecast, by product
      • 6.5.2.8.Rest of LAMEA market size & forecast, by end user
    • 6.5.3.LAMEA market size & forecast, by product
    • 6.5.4.LAMEA market size & forecast, by end user

CHAPTER 7:COMPANY PROFILES

  • 7.1.ADHERIUM
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Product portfolio
    • 7.1.4.Business performance
    • 7.1.5.Key strategic moves and development
  • 7.2.ASTRAZENECA PLC
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Product portfolio
    • 7.2.4.Business performance
    • 7.2.5.Key strategic moves and developments
  • 7.3.COHERO HEALTH, INC.
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Business segment
    • 7.3.4.Product portfolio
    • 7.3.5.Key strategic moves and developments
  • 7.4.GLAXOSMITHKLINE PLC
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
  • 7.5.HEALTH CARE ORIGINALS
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.3.Product portfolio
    • 7.5.4.Key strategic moves and development
  • 7.6.KONINKLIJKE PHILIPS N.V.
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Business performance
  • 7.7.PROPELLER HEALTH
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product Portfolio
    • 7.7.5.Key strategic moves and developments
  • 7.8.TEVA PHARMACEUTICAL INDUSTRIES LTD. (GECKO HEALTH INNOVATIONS)
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segments
    • 7.8.4.Product portfolio
    • 7.8.5.Business performance
  • 7.9.VECTURA GROUP PLC
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance
    • 7.9.6.Key strategic Moves and Development
  • 7.10.VOLANSYS TECHNOLOGIES
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio

LIST OF TABLES

  • TABLE 01.GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 02.GLOBAL WEARABLE ASTHMA MONITORING DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03.GLOBAL SMART INHALERS MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 04.GLOBAL INHALERS MARKET, BY TYPE, 2020-2030 ($MILLION)
  • TABLE 05.GLOBAL SMART INHALERS MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 06.GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 07.GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08.GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR HOMECARE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR CLINICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 12.U.S. INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 13.U.S. INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 14.CANADA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 15.CANADA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 16.MEXICO INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 17.MEXICO INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 18.NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 19.NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 20.EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 21.GERMANY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 22.GERMANY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 23.FRANCE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 24.FRANCE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 25.UK INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 26.UK INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 27.ITALY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
  • TABLE 28.ITALY INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 29.SPAIN INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
  • TABLE 30.SPAIN INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 31.REST OF EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 32.REST OF EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 33.EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 34.EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 35.ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 36.JAPAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 37.JAPAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 38.CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 39.CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 40.INDIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 41.INDIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 42.AUSTRALIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 43.AUSTRALIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 44.REST OF ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 45.REST OF ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 46.ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 47.ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 48.LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 49.BRAZIL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 50.BRAZIL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 51.SOUTH AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 52.SOUTH AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 53.SAUDI ARABIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 54.SAUDI ARABIA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 55.REST OF LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 56.REST OF LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 57.LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 58.LAMEA INTELLIGENT ASTHMA MONITORING DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 59.ADHERIUM: COMPANY SNAPSHOT
  • TABLE 60.ADHERIUM: PRODUCT PORTFOLIO
  • TABLE 61.ADHERIUM: PRODUCT PORTFOLIO
  • TABLE 62.ASTRAZENECA: COMPANY SNAPSHOT
  • TABLE 63.ASTRAZENECA: PRODUCT PORTFOLIO
  • TABLE 64.COHERO HEALTH, LLC: COMPANY SNAPSHOT
  • TABLE 65.COHERO HEALTH, LLC: PRODUCT PORTFOLIO
  • TABLE 66.COHERO HEALTH, LLC: PRODUCT PORTFOLIO
  • TABLE 67.GSK: COMPANY SNAPSHOT
  • TABLE 68.GSK: OPERATING SEGMENTS
  • TABLE 69.GSK: PRODUCT PORTFOLIO
  • TABLE 70.GSK: RECENT DEVELOPMENT
  • TABLE 71.HEALTH CARE ORIGINALS: COMPANY SNAPSHOT
  • TABLE 72.HEALTH CARE ORIGINALS: PRODUCT PORTFOLIO
  • TABLE 73.HEALTH CARE ORIGINALS: RECENT DEVELOPMENT
  • TABLE 74.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 75.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
  • TABLE 76.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 77.PROPELLER: COMPANY SNAPSHOT
  • TABLE 78.PROPELLER: COMPANY SNAPSHOT
  • TABLE 79.TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
  • TABLE 80.TEVA PHARMACEUTICAL INDUSTRIES LTD.: OPERATING SEGMENTS
  • TABLE 81.TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
  • TABLE 82.VECTURA GROUP PLC: COMPANY SNAPSHOT
  • TABLE 83.VECTURA GROUP PLC: OPERATING SEGMENTS
  • TABLE 84.VECTURA GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 85.VOLANSYS TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 86.VOLANSYS TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 87.VOLANSYS TECHNOLOGIES: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.INTELLIGENT ASTHMA MONITORING DEVICES MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021 (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.HIGH THREAT OF SUBSTITUTES
  • FIGURE 09.LOW THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE INTENSITY OF RIVALRY
  • FIGURE 11.MARKET SHARE ANALYSIS
  • FIGURE 12.MARKET DYNAMICS
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF WEARABLE ASTHMA MONITORING DEVICES MARKET, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 14.GLOBAL DRY POWDERED DOSE INHALER MARKET, 2020-2030 ($MILLION)
  • FIGURE 15.GLOBAL METERED DOSE INHALER MARKET, 2017-2025 ($MILLION)
  • FIGURE 16.GLOBAL NEBULIZERS SMART INHALER MARKET, 2020-2030 ($MILLION)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SMART INHALER MARKET, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR HOMECARE, BY COUNTRY, 2017 & 2025 (%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF INTELLIGENT ASTHMA MONITORING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 21.ADHERIUM: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 22.ADHERIUM: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 23.ASTRAZENECA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 24.ASTRAZENECA: REVENUE SHARE BY PRODUCT, 2020 (%)
  • FIGURE 25.ASTRAZENECA: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 26.GSK: NET SALES, 2015-2017 ($MILLION)
  • FIGURE 27.GSK: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 28.GSK: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 29.KONINKLIJKE PHILIPS N.V.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 30.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 31.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2017 (%)
  • FIGURE 32.TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET SALES, 2020-2030 ($MILLION)
  • FIGURE 33.TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE SHARE, BY REGION, 2017 (%)
  • FIGURE 34.VECTURA GROUP PLC: NET SALES, 2020-2030 ($MILLION)
  • FIGURE 35.VECTURA GROUP PLC: REVENUE SHARE BY REGION, 2020 (%)